What are the relative health outcomes of the CDC advisory committee patients?

Enquiring minds want to know if the health outcomes for conditions and diseases treated by the members of APIC show a marked improvement over those of the majority of others treating those diseases and conditions.

If the outcomes for patients are markedly better than those of others, then APIC members should demonstrate their success and improve the treatment methods used by others. If not, they should note the treatment methods of others and adopt those to improve the outcomes for all patients these APIC members are involved with.

Many of these members are involved in teaching medicine. Given the complete disregard for placing disease risk in the context of treatment harms, it is likely that they are instilling the same "values” amongst all they come into contact with.

I won’t hold my breath.

Here is the committee and its members.

Members of ACIP are here:

https://www.cdc.gov/vaccines/acip/members/bios.html

    Lynn Bahta, RN, MPH, CPH

    Beth P. Bell, MD, MPH

    Oliver Brooks, MD, FAAP

    Wilbur H. Chen, MD, MS, FIDSA, FACP

    Sybil Cineas, MD, FAAP, FACP

    Matthew F. Daley, MD

    Camille N. Kotton, MD, FIDSA, FAST

    James Loehr, MD, FAAFP

    Grace M. Lee, MD, MPH

    Sarah S. Long, MD

    Veronica V. McNally, J.D.

    Katherine A. Poehling, MD, MPH

    Pablo J. Sanchez, M.D.

    Nirav D. Shah, MD, JD

    Helen Keipp Talbot, MD, MPH